EDITION:

Search
Search
Close this search box.

Larry Lisser, SVP, HelloMD

BofCbyBofC
May 5, 2020
in Business of Cannabis North America, Events, Lunch + Learn
Share on FacebookShare on Twitter

Larry Lisser is the SVP at HelloMD a telehealth platform that connects patients to thoughtful information about medical cannabis and provides authorizations for medical cannabis patients in Canada. Their platform is directly integrated into the Shoppers Drug Mart’s Medical Cannabis portal and has become a go-to source for patience seeking guidance about medical cannabis.

Lisser will join BofC for this Lunch+Learn to talk about how medical cannabis access has changed during COVID-19 and how HelloMD is helping patients along the way.

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required

Premium Data Packs

Save 15%
Medical Market Sizing – Key International Markets £2,049£1,742
Market sizing & patient forecasts for 14 markets (2026–2030). Includes scenario forecasting for Australia & Germany.
UK & Germany Distributor Portfolios £1,625£1,381
Evolution of distributor product portfolios by product count.
UK & Germany Product & Pricing £1,869£1,589
Monthly pricing development, average pricing by month and product format.
Export/Import Comparison £1,265£1,075
Key market import/export volumes with export and import market comparisons.
Price Evolution – UK & Germany £1,329£1,130
Average price evolution comparison between UK and Germany markets.
Pre-order data packs → Data packs delivered digitally in January 2026. Pre-order pricing available until January 15.
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant
Tags:
BofC

BofC

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

Tags:
The trusted global news source for cannabis.

Categories

EDITIONS

POPULAR

Tags
#Cannabis Capital Markets #European cannabis #Europe CBD #Novel Food adult use business of cannabis california canada cannabis cannabis benchmarks cannabis cultivation cannabis industry cannabis news cannabis policy Cannabis products cannabis retail cbd CBD industry CBD products dea europe event featured germany health canada hemp innovation international jay rosenthal legalization marijuana markets medical cannabis medicinal cannabis newsletter new york ontario prohibition partners regulations Rescheduling retail technology uk united states us

Business of cannabis

CONNECT

CONTACT

© 2024 Prohibition Holdings Ltd. All Rights Reserved.

No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.

CATEGORIES

NewsGlobal Cannabis News & Analysis | Business of Cannabis
Latest NewsDaily cannabis news and breaking stories from markets, policy, and medical sectors worldwide.
Industry TrendsExplore long-term trends shaping the global cannabis economy, from legalisation to innovation.
OpinionRead expert opinions and analysis on policy, markets, and culture in the cannabis industry.
Editorial PicksHand-picked stories offering depth, insight, and perspective on global cannabis developments.
Markets & StocksStay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Cannabis Stocks Tracker
Public MarketsExplore the top publicly listed cannabis firms and market trends driving global valuation.
Investment & FinanceInsight into funding rounds, venture capital, and financial strategy shaping cannabis growth.
M&A ActivityThe latest mergers, acquisitions, and strategic partnerships transforming the cannabis sector.
Policy & RegulationStay informed about the latest cannabis regulation developments and changes with Business of Cannabis. Learn about new laws, policies and more.
UK & EuropeIn-depth coverage of regulatory change and licensing frameworks across the UK & EU.
US & CanadaAnalysis of federal and state cannabis reform shaping the North American market.
International RegulationCountry-by-country insight on legalisation models, trade rules, and compliance trends.
Legal AnalysisExpert commentary on cannabis law, IP, advertising, and risk management worldwide.
MedicalStay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical CannabisScience-led insight on therapeutic use, formulations, and clinical best practice.
Clinical Research Repository
Patient AccessHow patients obtain medical cannabis through licensed clinics and specialist prescribers.
Prescribers & ClinicsResources and governance insight for clinicians and healthcare providers.
PharmaceuticalLearn about the latest developments in the pharmaceutical cannabis industry with Business of Cannabis. Discover new drugs, research, and more.
CBD & HempData-driven coverage of CBD innovation, hemp policy, and wellness applications.
CBD MarketStay informed about the latest trends and developments in the CBD industry with Business of Cannabis. Discover new products, industry insights, and more.
Hemp IndustryExplore the latest developments in the hemp industry with Business of Cannabis. Find out about new products, regulations, and more.
ProductsWhat to look for in CBD oils, edibles, and supplements — testing, safety, and labelling.
BusinessIntelligence for founders, operators, and investors building sustainable cannabis ventures.
Start-UpsEntrepreneur stories, funding pathways, and lessons from emerging cannabis companies.
Retail & BrandsHow leading cannabis retailers and brands design, market, and scale in regulated markets.
Cultivation
Supply ChainDistribution, compliance, and efficiency trends powering cannabis supply networks.
CompaniesStay informed about the latest developments and news from cannabis companies with Business of Cannabis. Learn about new products, mergers and acquisitions, and more.
Press releasesStay informed about the latest developments and official statements in the cannabis industry with Business of Cannabis’ collection of press releases. Learn about new products, industry news and more from top companies.
InterviewsExclusive conversations with CEOs and founders defining the cannabis economy.
Upcoming EventsStay informed about upcoming cannabis events and conferences with Business of Cannabis. Learn about new products, industry insights, and more.
BofC New York
Cannabis Health Symposium
Cannabis Europa
Previous EventsStay informed about upcoming cannabis events and conferences with Business of Cannabis. Learn about new products, industry insights, and more.
BofC Awards 2025
BofC x MJ Berlin

EDITION

BUSINESS OF CANNABIS

Twitter Facebook Instagram Linkedin Youtube

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?